Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SHE:301234)
China · Delayed Price · Currency is CNY 131.65
+2.65 (2.05%)
At close: Oct 23, 2026
SHE:301234 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 412.8 | 458.04 | 477.23 | 533.5 | 546.78 | 512.79 |
Other Revenue | 0.24 | 0.24 | 0.2 | 0.18 | 0.33 | 0.18 |
| 413.03 | 458.28 | 477.43 | 533.68 | 547.11 | 512.96 | |
Revenue Growth | -14.00% | -4.01% | -10.54% | -2.46% | 6.66% | 8.85% |
Cost of Revenue | 345.66 | 392.98 | 395.53 | 422.68 | 428.74 | 399.7 |
Gross Profit | 67.38 | 65.3 | 81.9 | 111 | 118.38 | 113.26 |
Selling, General & Admin | 37.8 | 37.74 | 33.06 | 35.25 | 43.31 | 19.93 |
Research & Development | 10.87 | 9.74 | 12.97 | 13.48 | 13.09 | 11.78 |
Other Operating Expenses | -2.94 | 1.37 | 1.54 | 1.56 | 1.82 | 2.6 |
Operating Expenses | 46.29 | 48.09 | 49.35 | 53.43 | 63.13 | 35.07 |
Operating Income | 21.09 | 17.21 | 32.55 | 57.56 | 55.25 | 78.19 |
Interest Expense | -0 | -0.02 | -0.02 | -0.01 | -0.63 | -1.03 |
Interest & Investment Income | 7.01 | 7.96 | 5.69 | 8.72 | 2.11 | 2.29 |
Currency Exchange Gain (Loss) | -0.63 | -0.63 | 5.66 | 3.56 | 7.06 | -2.49 |
Other Non Operating Income (Expenses) | -4.97 | -0.22 | -0.91 | -1.37 | -0.65 | -0.81 |
EBT Excluding Unusual Items | 22.5 | 24.31 | 42.97 | 68.46 | 63.14 | 76.15 |
Gain (Loss) on Sale of Investments | 0.23 | -0.24 | 0.9 | -1.34 | -6.15 | - |
Gain (Loss) on Sale of Assets | 0.75 | -0.03 | 0.01 | - | - | -0.47 |
Asset Writedown | -3.26 | -1.58 | -0.32 | -0.47 | -1.94 | -0.01 |
Other Unusual Items | 0.07 | 0.43 | 2.89 | 4.29 | 18.4 | 4.17 |
Pretax Income | 20.29 | 22.89 | 46.45 | 70.94 | 73.45 | 79.84 |
Income Tax Expense | 2.37 | 4 | 6.49 | 10.67 | 2.52 | 11.45 |
Net Income | 17.92 | 18.89 | 39.97 | 60.27 | 70.93 | 68.39 |
Net Income to Common | 17.92 | 18.89 | 39.97 | 60.27 | 70.93 | 68.39 |
Net Income Growth | -25.79% | -52.73% | -33.68% | -15.04% | 3.71% | 20.53% |
Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 60 | 51 |
Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 60 | 51 |
Shares Change | 0.03% | 0.01% | 0.00% | 14.28% | 16.66% | -0.24% |
EPS (Basic) | 0.26 | 0.28 | 0.59 | 0.89 | 1.19 | 1.34 |
EPS (Diluted) | 0.26 | 0.28 | 0.59 | 0.89 | 1.19 | 1.34 |
EPS Growth | -25.82% | -52.74% | -33.68% | -25.65% | -11.10% | 20.81% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 6.99 | 53.61 | 51.9 | 10.92 | -52.51 | 6.07 |
Free Cash Flow Per Share | 0.10 | 0.79 | 0.76 | 0.16 | -0.88 | 0.12 |
Dividend Per Share | 0.200 | 0.200 | 0.300 | 0.400 | 0.500 | - |
Dividend Growth | -33.33% | -33.33% | -25.00% | -20.00% | - | - |
Gross Margin | 16.31% | 14.25% | 17.16% | 20.80% | 21.64% | 22.08% |
Operating Margin | 5.11% | 3.75% | 6.82% | 10.79% | 10.10% | 15.24% |
Profit Margin | 4.34% | 4.12% | 8.37% | 11.29% | 12.96% | 13.33% |
Free Cash Flow Margin | 1.69% | 11.70% | 10.87% | 2.04% | -9.60% | 1.18% |
EBITDA | 58.88 | 55.17 | 70.74 | 87.81 | 77.7 | 96.36 |
EBITDA Margin | 14.26% | 12.04% | 14.82% | 16.45% | 14.20% | 18.79% |
D&A For EBITDA | 37.79 | 37.96 | 38.18 | 30.25 | 22.45 | 18.17 |
EBIT | 21.09 | 17.21 | 32.55 | 57.56 | 55.25 | 78.19 |
EBIT Margin | 5.11% | 3.75% | 6.82% | 10.79% | 10.10% | 15.24% |
Effective Tax Rate | 11.69% | 17.47% | 13.96% | 15.05% | 3.43% | 14.34% |
Revenue as Reported | 112.86 | 458.28 | 477.43 | 533.68 | 547.11 | 512.96 |
Advertising Expenses | - | 2.2 | 1.65 | 1.44 | 0.78 | 0.66 |